Search

everythinglearnresearchcommunity

for

Search:↓

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Stress increases certain chemicals in the skin and nerves, which might worsen skin conditions.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Blocking CRF-R1 can reduce alcohol intake in stressed mice.

Adrenal disorders can cause lasting brain and behavior issues in children.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Minoxidil helps prevent stress-caused hair loss in mice.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Pregnancy reduces anxiety in rats, but finasteride reverses this effect.

An enzyme other than TNAP might be responsible for vitamin B-6 metabolism in the skin.